Biophytis SA banner

Biophytis SA
PAR:ALBPS

Watchlist Manager
Biophytis SA Logo
Biophytis SA
PAR:ALBPS
Watchlist
Price: 0.017 EUR -2.3% Market Closed
Market Cap: €1.6m

Biophytis SA
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Biophytis SA
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Biophytis SA
PAR:ALBPS
EPS (Diluted)
€0
CAGR 3-Years
-23%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
EPS (Diluted)
€0
CAGR 3-Years
18%
CAGR 5-Years
1%
CAGR 10-Years
-9%
G
Genfit SA
PAR:GNFT
EPS (Diluted)
-€1
CAGR 3-Years
-53%
CAGR 5-Years
8%
CAGR 10-Years
-10%
Inventiva SA
PAR:IVA
EPS (Diluted)
-€1
CAGR 3-Years
-13%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
DBV Technologies SA
PAR:DBV
EPS (Diluted)
-$1
CAGR 3-Years
5%
CAGR 5-Years
19%
CAGR 10-Years
7%
Abivax SA
PAR:ABVX
EPS (Diluted)
-€4
CAGR 3-Years
-10%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
No Stocks Found

Biophytis SA
Glance View

Market Cap
1.6m EUR
Industry
Biotechnology

Biophytis SA is a holding company. The company is headquartered in Paris, Ile-De-France and currently employs 24 full-time employees. The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.

ALBPS Intrinsic Value
LOCKED
Unlock

See Also

What is Biophytis SA's EPS (Diluted)?
EPS (Diluted)
-0.4 EUR

Based on the financial report for Jun 30, 2025, Biophytis SA's EPS (Diluted) amounts to -0.4 EUR.

What is Biophytis SA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
6%

Over the last year, the EPS (Diluted) growth was 90%. The average annual EPS (Diluted) growth rates for Biophytis SA have been -23% over the past three years , 6% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett